Lumpectomy is a surgical procedure that removes the tumor and some of the surrounding tissue. It is used to treat breast cancer in women who are not candidates for mastectomy. The market share of lumpectomy systems in 2018 is about 71%. And the lumpectomy surgical tool developed fast, with the CAGR of 7.21% during 2014 to 2019. Lumpectom has been widely used in hospitals, ambulatory surgical centers and other medical institutions for breast cancer treatment. By application, hospitals is the largest segment, with market share of 69% in 2018. North America was the largest region by revenue and accounted for about 44% of total revenue in 2018 due to its high adoption rate among patients suffering from breast cancer as well as its high healthcare expenditure per capita which leads to higher demand for lumpectomies than other regions such as Asia Pacific or Latin America.
Some Of The Growth Factors Of This Market:
- The number of breast cancer cases is increasing in the United States and other countries.
- The number of women who are diagnosed with breast cancer is increasing as well, which means more people are at risk for a lumpectomy procedure.
- More people are living longer after a lumpectomy procedure, which means they will need to have their breasts checked regularly for recurrence of the disease or other health problems that may arise from having had a lumpectomy procedure.
- There is an increased awareness about the benefits of early detection and treatment for breast cancer.
- There has been an increase in research on new treatments for breast cancer.
Industry Growth Insights published a new data on “Lumpectomy Market”. The research report is titled “Lumpectomy Market research by Types (Lumpectomy Systems, Lumpectomy Surgical Tools, The market share of lumpectomy systems in 2018 is about 71%. And the lumpectomy surgical tool developed fast, with the CAGR of 7.21% during 2014 to 2019., Lumpectom), By Applications (Hospitals, Ambulatory Surgical Centers, By application, hospitals is the largest segment, with market share of 69% in 2018.), By Players/Companies Hologic, BD, Danaher, Cook Medical, Carl Zeiss Meditech, Merit Medical, Argon Medical Devices, Eckert & Ziegler, Theragenics, Sanarus, IsoAid, SOMATEX Medical, Ranfac, STERYLAB, Endomagnetics, Lumpectom”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Lumpectomy Market Research Report
By Type
Lumpectomy Systems, Lumpectomy Surgical Tools, The market share of lumpectomy systems in 2018 is about 71%. And the lumpectomy surgical tool developed fast, with the CAGR of 7.21% during 2014 to 2019., Lumpectom
By Application
Hospitals, Ambulatory Surgical Centers, By application, hospitals is the largest segment, with market share of 69% in 2018.
By Companies
Hologic, BD, Danaher, Cook Medical, Carl Zeiss Meditech, Merit Medical, Argon Medical Devices, Eckert & Ziegler, Theragenics, Sanarus, IsoAid, SOMATEX Medical, Ranfac, STERYLAB, Endomagnetics, Lumpectom
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Lumpectomy Market Report Segments:
The global Lumpectomy market is segmented on the basis of:
Types
Lumpectomy Systems, Lumpectomy Surgical Tools, The market share of lumpectomy systems in 2018 is about 71%. And the lumpectomy surgical tool developed fast, with the CAGR of 7.21% during 2014 to 2019., Lumpectom
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgical Centers, By application, hospitals is the largest segment, with market share of 69% in 2018.
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Hologic
- BD
- Danaher
- Cook Medical
- Carl Zeiss Meditech
- Merit Medical
- Argon Medical Devices
- Eckert & Ziegler
- Theragenics
- Sanarus
- IsoAid
- SOMATEX Medical
- Ranfac
- STERYLAB
- Endomagnetics
- Lumpectom
Highlights of The Lumpectomy Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Lumpectomy Systems
- Lumpectomy Surgical Tools
- The market share of lumpectomy systems in 2018 is about 71%. And the lumpectomy surgical tool developed fast, with the CAGR of 7.21% during 2014 to 2019.
- Lumpectom
- By Application:
- Hospitals
- Ambulatory Surgical Centers
- By application, hospitals is the largest segment, with market share of 69% in 2018.
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Lumpectomy Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Lumpectomy is a surgery that removes part of the breast.
Some of the major companies in the lumpectomy market are Hologic, BD, Danaher, Cook Medical, Carl Zeiss Meditech, Merit Medical, Argon Medical Devices, Eckert & Ziegler, Theragenics, Sanarus, IsoAid, SOMATEX Medical, Ranfac, STERYLAB, Endomagnetics, Lumpectom.
The lumpectomy market is expected to register a CAGR of 7.21%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Lumpectomy Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Lumpectomy Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Lumpectomy Market - Supply Chain
4.5. Global Lumpectomy Market Forecast
4.5.1. Lumpectomy Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Lumpectomy Market Size (000 Units) and Y-o-Y Growth
4.5.3. Lumpectomy Market Absolute $ Opportunity
5. Global Lumpectomy Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Lumpectomy Market Size and Volume Forecast by Type
5.3.1. Lumpectomy Systems
5.3.2. Lumpectomy Surgical Tools
5.3.3. The market share of lumpectomy systems in 2018 is about 71%. And the lumpectomy surgical tool developed fast, with the CAGR of 7.21% during 2014 to 2019.
5.3.4. Lumpectom
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Lumpectomy Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Lumpectomy Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Ambulatory Surgical Centers
6.3.3. By application, hospitals is the largest segment, with market share of 69% in 2018.
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Lumpectomy Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Lumpectomy Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Lumpectomy Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Lumpectomy Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Lumpectomy Demand Share Forecast, 2019-2026
9. North America Lumpectomy Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Lumpectomy Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Lumpectomy Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Ambulatory Surgical Centers
9.4.3. By application, hospitals is the largest segment, with market share of 69% in 2018.
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Lumpectomy Market Size and Volume Forecast by Type
9.7.1. Lumpectomy Systems
9.7.2. Lumpectomy Surgical Tools
9.7.3. The market share of lumpectomy systems in 2018 is about 71%. And the lumpectomy surgical tool developed fast, with the CAGR of 7.21% during 2014 to 2019.
9.7.4. Lumpectom
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Lumpectomy Demand Share Forecast, 2019-2026
10. Latin America Lumpectomy Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Lumpectomy Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Lumpectomy Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. By application, hospitals is the largest segment, with market share of 69% in 2018.
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Lumpectomy Market Size and Volume Forecast by Type
10.7.1. Lumpectomy Systems
10.7.2. Lumpectomy Surgical Tools
10.7.3. The market share of lumpectomy systems in 2018 is about 71%. And the lumpectomy surgical tool developed fast, with the CAGR of 7.21% during 2014 to 2019.
10.7.4. Lumpectom
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Lumpectomy Demand Share Forecast, 2019-2026
11. Europe Lumpectomy Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Lumpectomy Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Lumpectomy Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Ambulatory Surgical Centers
11.4.3. By application, hospitals is the largest segment, with market share of 69% in 2018.
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Lumpectomy Market Size and Volume Forecast by Type
11.7.1. Lumpectomy Systems
11.7.2. Lumpectomy Surgical Tools
11.7.3. The market share of lumpectomy systems in 2018 is about 71%. And the lumpectomy surgical tool developed fast, with the CAGR of 7.21% during 2014 to 2019.
11.7.4. Lumpectom
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Lumpectomy Demand Share, 2019-2026
12. Asia Pacific Lumpectomy Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Lumpectomy Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Lumpectomy Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Ambulatory Surgical Centers
12.4.3. By application, hospitals is the largest segment, with market share of 69% in 2018.
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Lumpectomy Market Size and Volume Forecast by Type
12.7.1. Lumpectomy Systems
12.7.2. Lumpectomy Surgical Tools
12.7.3. The market share of lumpectomy systems in 2018 is about 71%. And the lumpectomy surgical tool developed fast, with the CAGR of 7.21% during 2014 to 2019.
12.7.4. Lumpectom
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Lumpectomy Demand Share, 2019-2026
13. Middle East & Africa Lumpectomy Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Lumpectomy Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Lumpectomy Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Ambulatory Surgical Centers
13.4.3. By application, hospitals is the largest segment, with market share of 69% in 2018.
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Lumpectomy Market Size and Volume Forecast by Type
13.7.1. Lumpectomy Systems
13.7.2. Lumpectomy Surgical Tools
13.7.3. The market share of lumpectomy systems in 2018 is about 71%. And the lumpectomy surgical tool developed fast, with the CAGR of 7.21% during 2014 to 2019.
13.7.4. Lumpectom
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Lumpectomy Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Lumpectomy Market: Market Share Analysis
14.2. Lumpectomy Distributors and Customers
14.3. Lumpectomy Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Hologic
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. BD
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Danaher
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Cook Medical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Carl Zeiss Meditech
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Merit Medical
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Argon Medical Devices
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Eckert & Ziegler
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Theragenics
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Sanarus
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. IsoAid
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. SOMATEX Medical
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Ranfac
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. STERYLAB
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Endomagnetics
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Lumpectom
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
